Claritas Pharmaceuticals
0 followers
‌
Claritas Pharmaceuticals is developing R-107, a nitric oxide-releasing molecule designed to treat vaccine-resistant COVID-19 infection.
Industries
Headquarters
Employees
Links
Org chart
Robert Farrell
President & CEO
Robert Farrell
Collapse
Nedira Frenkel
Director, Business Development
Yousif Sahly
Director, Quality Control
Gali Guzikevich
Director, Quality Assurance
Amos Rosenthal
Head, Chemistry
Iris Maimon
Director, Drug Development
Similar companies
Myonex
1 follower
NYU Langone Health
12 followers
PCI Pharma Services
6 followers
Parexel
6 followers
DispatchHealth
6 followers
West Pharmaceutical Services
5 followers
Cybrexa Therapeutics
1 follower
Vanda Pharmaceutical
4 followers
Navitus Health
3 followers
AbbVie
157 followers
Signant Health
2 followers
Discover companies